Literature DB >> 1641982

The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.

H G Göttlinger1, T Dorfman, E A Cohen, W A Haseltine.   

Abstract

The requirement for tnv, a tat-env-rev fusion protein expressed by the IIIB strain of HIV-1, was tested. The expression of tnv was prevented by altering the 5' splice site that flanks the central coding exon of tnv. Mutants that carry such an altered 5' splice site replicate normally in an established T-cell line and in peripheral blood lymphocytes, demonstrating that tnv has no effect on virus replication. However, two mutants that carry an alteration in the 3' splice site of the same exon are replication defective. The 3' splice site mutations result in significant reduction in the expression of the 16-kDa tat protein and induce the expression of large amounts of a 19-kDa rev-related protein that initiates within the central coding exon of tnv. S1 nuclease analysis reveals that splicing to the central tnv exon occurs with substantially increased efficiency via the use of an alternate 3' splice site six nucleotides 3' from the mutated site. The effect of the 3' splice site mutations on viral protein expression and replication are fully reversed by a second site mutation that eliminates the alternate splice site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641982     DOI: 10.1016/0042-6822(92)90585-d

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.

Authors:  Massimo Caputi; Alan M Zahler
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.

Authors:  M P Wentz; B E Moore; M W Cloyd; S M Berget; L A Donehower
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.

Authors:  Joshua M Madsen; C Martin Stoltzfus
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Identification of a novel splice acceptor in the HIV-1 genome: independent expression of the cytoplasmic tail of the envelope protein.

Authors:  B Berkhout; J L van Wamel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Utilization of host SR protein kinases and RNA-splicing machinery during viral replication.

Authors:  Takeshi Fukuhara; Takamitsu Hosoya; Saki Shimizu; Kengo Sumi; Takako Oshiro; Yoshiyuki Yoshinaka; Masaaki Suzuki; Naoki Yamamoto; Leonore A Herzenberg; Leonard A Herzenberg; Masatoshi Hagiwara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-13       Impact factor: 11.205

6.  Development of an HIV reporter virus that identifies latently infected CD4+ T cells.

Authors:  Eun Hye Kim; Lara Manganaro; Michael Schotsaert; Brian D Brown; Lubbertus C F Mulder; Viviana Simon
Journal:  Cell Rep Methods       Date:  2022-06-13

7.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

Authors:  D F Purcell; M A Martin
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron.

Authors:  M L Hammarskjöld; H Li; D Rekosh; S Prasad
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.

Authors:  Massimo Caputi; Marcel Freund; Susanne Kammler; Corinna Asang; Heiner Schaal
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.

Authors:  F Mammano; E Kondo; J Sodroski; A Bukovsky; H G Göttlinger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.